Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Mounjaro (tirzepatide) and Wegovy (semaglutide) are both FDA-approved weight loss medications that work through GLP-1 and other hormone pathways, yet they produce different side effect profiles in different people. Understanding these differences matters because tolerability directly affects your ability to stay on treatment long enough to see real results. PlexusDx offers both medications from licensed 503A compounding pharmacies, so you can explore which one aligns better with your health goals and genetic makeup.
How Mounjaro and Wegovy Work Differently in Your Body
Wegovy contains semaglutide, a single-action GLP-1 receptor agonist that mimics a hormone your gut naturally produces. This hormone slows stomach emptying, reduces hunger signals in the brain, and improves how your body manages blood sugar. Mounjaro (tirzepatide) is a dual-action medication: it activates both GLP-1 and GIP receptors simultaneously. This dual mechanism often produces stronger appetite suppression and faster weight loss in clinical trials, but it can also trigger more intense side effects initially.
The structural difference between these two medications explains why some people tolerate one better than the other. Semaglutide has been studied for over a decade, giving physicians and patients extensive real-world experience with its safety profile. Tirzepatide is newer and offers a more aggressive approach to weight loss—which benefits some patients but may overwhelm others, especially early in treatment. PlexusDx Precision Peptide Genetic Test examines your GLP1R and GIPR genetic variants to predict which medication pathway your body may respond to more favorably.
Gastrointestinal Side Effects: Which Is Worse?
Nausea is the most commonly reported side effect for both medications, affecting 25–40% of users in clinical trials. With Wegovy, nausea typically appears within the first two weeks and often improves as your body adapts and your dose stabilizes. Mounjaro users report similarly high rates of nausea, but some experience it more intensely during the first month because tirzepatide's dual-receptor activation is stronger. Vomiting, constipation, and diarrhea can occur with both, though rates vary widely between individuals.
The timing and severity of GI side effects depend partly on how quickly your dose increases. PlexusDx compounded tirzepatide and semaglutide allow for slower, more gradual dose titration than typical pharmacy versions, reducing the shock to your digestive system. Studies show that patients who start at lower doses and increase slowly experience fewer dropouts due to side effects. Both medications can cause appetite loss so profound that eating feels like a chore—a feature that aids weight loss but requires nutrition planning to prevent deficiency.
Injection Site Reactions and Systemic Side Effects
Both Mounjaro and Wegovy come as once-weekly subcutaneous injections, and both can cause mild redness, bruising, or discomfort at the injection site. These local reactions are usually temporary and resolve within hours to days. Systemic side effects—fatigue, dizziness, headache, and muscle aches—occur in roughly 10–20% of users and tend to fade after the first month as your body adjusts. Some patients report these effects more prominently with tirzepatide because of its stronger mechanism of action.
Pancreatitis, though rare (less than 1% in trials), has been reported with both GLP-1 and GIP receptor agonists. Symptoms include severe upper abdominal pain, vomiting, and elevated pancreatic enzymes. If you experience these signs, stop the medication and seek immediate medical attention. PlexusDx recommends baseline liver and pancreatic function tests before starting either medication, and periodic monitoring during the first three months of treatment.
Which Medication Suits Your Body: Personalized Selection at PlexusDx
Choosing between Mounjaro and Wegovy should not rely on guesswork. Your genetic profile influences how strongly you respond to GLP-1 versus GIP signaling, and variants in your GLP1R, GIPR, and FTO genes predict which medication may deliver faster, more tolerable weight loss. PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 49 peptides tied to appetite, satiety, and medication response. This data transforms a coin-flip decision into a science-backed strategy.
PlexusDx compounded tirzepatide starts at $249/month and compounded semaglutide at $149/month—both offered at flat monthly pricing with no dose-based markup. Your dose may need to go up as treatment progresses, but your price won't. HSA and FSA accounts cover both medications, and PlexusDx serves all 50 states without requiring insurance or membership fees. Many patients start with semaglutide for gentler initial tolerability, then switch to tirzepatide after building tolerance—a flexibility that compounded options from licensed 503A pharmacies enable more easily than branded versions.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does Mounjaro cause worse nausea than Wegovy?
Both trigger nausea in similar proportions of users, but tirzepatide's dual-receptor action can feel more intense early on. Slower dose escalation with PlexusDx compounded versions often reduces nausea severity. Individual tolerance depends heavily on genetics and stomach sensitivity.
Can I switch from Wegovy to Mounjaro if I'm not tolerating it well?
Yes. Many patients transition between semaglutide and tirzepatide depending on how their body adapts. PlexusDx allows straightforward medication switches and can adjust your compounding formula to support the transition without losing progress.
Which medication causes more weight loss?
Clinical trials show tirzepatide (Mounjaro) typically produces 15–22% body weight reduction, while semaglutide (Wegovy) achieves 10–18%. However, individual results vary significantly based on genetics, adherence, and lifestyle. PlexusDx genetic testing helps predict which medication will deliver stronger results for your body.
How long do side effects last on these medications?
Most GI side effects peak during the first 2–4 weeks and improve substantially by week 6–8 as your body adapts. Injection site reactions typically resolve within hours. If side effects persist beyond 8 weeks, dose adjustment or medication switching may be necessary.
What does the PlexusDx genetic test tell me about which medication to choose?
The Precision Peptide Genetic Test examines GLP1R, GIPR, FTO, and MC4R variants that influence your appetite-control pathways. These insights help predict whether you'll respond more robustly to single-action (semaglutide) or dual-action (tirzepatide) therapy, reducing trial-and-error in medication selection.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating the Approval Process: How Long Does Insurance Take to Approve Ozempic?
Understanding Ozempic: Uses, Effects, and Management Strategies